Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
51.74 USD | -1.20% | -1.85% | +30.34% |
05-08 | Earnings Flash (KROS) KEROS THERAPEUTICS Reports Q1 Revenue $83,000 | MT |
05-08 | Keros Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+30.34% | 1.89B | |
+8.24% | 115B | |
+12.93% | 107B | |
-13.40% | 22.31B | |
-3.99% | 21.6B | |
-6.00% | 18.23B | |
-39.93% | 17.62B | |
+7.81% | 14.26B | |
+33.78% | 12.37B | |
-27.49% | 8.28B |
- Stock Market
- Equities
- KROS Stock
- News Keros Therapeutics, Inc.
- Keros Therapeutics Shares Fall After Reporting Additional Data From Trial of KER-050 With Potential for Treating Cytopenia